Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

Study:

CSP#424 - Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

Rationale:

n/a

Purpose:

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or nonfatal MI.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Myocardial Ischemia Procedure: Intensive medical therapy
Procedure: Percutaneous Coronary Intervention (PCI) plus intensive medical therapy
Phase 3

Verified by Department of Veterans Affairs June, 2007

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov identifier: NCT00007657

Study Type: Interventional

Study Design: Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Cleveland Clinic - Cleveland, OH
CLEVELAND, Ohio 44195-5066
United States

William E Boden, MD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site